Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001628280-16-018311
Filing Date
2016-08-03
Accepted
2016-08-02 17:31:52
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-1/A imuc_s1.htm S-1/A 816065
2 EXHIBIT 1.1 imuc-exhibit11.htm EX-1.1 284739
3 EXHIBIT 4.9 imuc-exhibit49.htm EX-4.9 119137
4 EXHIBIT 5.1 imuc-exhibit51.htm EX-5.1 12523
5 EXHIBIT 23.1 imuc-exhibit231.htm EX-23.1 3568
6 capture.jpg GRAPHIC 14802
7 cooleyimg.jpg GRAPHIC 5670
8 cooleyimga01.jpg GRAPHIC 5670
  Complete submission text file 0001628280-16-018311.txt   1268282
Mailing Address 23622 CALABASAS ROAD SUITE 300 CALABASAS CA 91302
Business Address 23622 CALABASAS ROAD SUITE 300 CALABASAS CA 91302 818-264-2300
ImmunoCellular Therapeutics, Ltd. (Filer) CIK: 0000822411 (see all company filings)

EIN.: 931301885 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-211763 | Film No.: 161801653
SIC: 2834 Pharmaceutical Preparations